Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Grady

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
British Journal of Haematology|August 1, 1976
Chelation studies with 2,3-dihydroxybenzoic acid in patients with beta-thalassaemia majorC M Peterson, J H Graziano, R W Grady, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
HTLV-III neutralizing antibody development in transfusion-dependent seropositive patients with beta-thalassemiaM Robert-Guroff, P J Giardina, W G Robey, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1979
Rhodotorulic acid--investigation of its potential as an iron-chelating drugR W Grady, C M Peterson, R L Jones, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery|August 27, 2014
Reconstruction of the symphysis pubis to repair a complex midline hernia in the setting of congenital bladder exstrophyJ E Kohler, J S Friedstat, M A Jacobs, et al.
Experimental Hematology|February 1, 1979
Chelation therapy in beta-thalassemia major: a one-year double blind study of 2,3-dihydroxybenzoic acidC M Peterson, J H Graziano, R W Grady, et al.
The New England Journal of Medicine|December 22, 1977
2,3-DHB ineffective in treatment of iron overloadC M Peterson, R W Grady, R L Jones, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
British Journal of Haematology|August 1, 1976
Chelation studies with 2,3-dihydroxybenzoic acid in patients with beta-thalassaemia majorC M Peterson, J H Graziano, R W Grady, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
HTLV-III neutralizing antibody development in transfusion-dependent seropositive patients with beta-thalassemiaM Robert-Guroff, P J Giardina, W G Robey, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1979
Rhodotorulic acid--investigation of its potential as an iron-chelating drugR W Grady, C M Peterson, R L Jones, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery|August 27, 2014
Reconstruction of the symphysis pubis to repair a complex midline hernia in the setting of congenital bladder exstrophyJ E Kohler, J S Friedstat, M A Jacobs, et al.
Experimental Hematology|February 1, 1979
Chelation therapy in beta-thalassemia major: a one-year double blind study of 2,3-dihydroxybenzoic acidC M Peterson, J H Graziano, R W Grady, et al.
The New England Journal of Medicine|December 22, 1977
2,3-DHB ineffective in treatment of iron overloadC M Peterson, R W Grady, R L Jones, et al.
Pageof 9